CareNX Innovations

India-based CareNX is decentralizing fetal monitoring by making its flagship AI-powered fetal heart-rate tool, Fetosense, open-source. Conventional fetal monitoring typically requires hospital equipment and trained specialists, but Fetosense enables a general practitioner or frontline worker to perform fetal screening on-site in lower-resourced or rural settings where an obstetrician may not be available. Fetosense’s AI and machine learning features help physicians spot early warning signs, and remote monitoring allows physicians to access nonstress tests (NSTs) and cardiotocography (CTG) results from anywhere. The company also offers SindiColpo, a cervical cancer screening tool that lets field nurses perform tests on women in community health camps and clinics.